One of the most common tests for cellular inflammation
VibrantAmerica (various)
Vibrant America is a leading science and technology company delivering laboratory services.
Biomarkers in this category
16 biomarkers · optimal ranges shown
present in wheat and other cereal
Intestinal Permeability Panel
Intestinal Permeability Panel
a 20-carbon polyunsaturated n-6 fatty acid with 4 double bonds
Species in the genus Bacteroides carry out broad metabolic functions, including degradation of complex plant polysaccharides, proteolytic activities, de-conjugation of bile acids, mucosal barrier integrity, short chain fatty acid production, fatty acid storage and glucose metabolism. Bacteroides spp. are maintained at a higher abundance in breastfed individuals into adulthood. Bacteroides fragilis plays an important role in the prevention of intestinal inflammation. An energy-restricted diet has been shown to increase B. fragilis in overweight adolescents. An increase in B. stercoris has been associated with higher risk of colon cancer. Decreased levels of Bacteroides spp. have been reported in association with multiple sclerosis, rheumatoid arthritis and Parkinson’s disease.
Bifidobacterium bifidum reduces Intestinal Inflammation. References: Ojima MN, Gotoh A, Takada H, Odamaki T, Xiao JZ, Katoh T, Katayama T. Bifidobacterium bifidum Suppresses Gut Inflammation Caused by Repeated Antibiotic Disturbance Without Recovering Gut Microbiome Diversity in Mice. Front Microbiol. 2020 Jun 18;11:1349. doi: 10.3389/fmicb.2020.01349. PMID: 32625197; PMCID: PMC7314955. [L]
Bifidobacterium infantis is a lactic-acid-producing gut bacteria that provides many benefits to newborn infants as well as adults. B. infantis is a bacterial species belonging to the Bifidobacteria genus. B. infantis is commonly seen in an infant’s digestive tract, particularly those who are breast fed. Unlike some other Bifidobacteria species, B. infantis does not tolerate oxygen very well, therefore B. infantis takes up its main residence in the colon. B. infantis is a beneficial microbe and can exert many positive effects supporting human health, thus making it of particular interest in the probiotic industry.
Can produce several endogenous infections
Linked to Parkinson’s disease
an important indicator of overall health
Eggerthella lenta is a normal human microflora that is anaerobic, non-sporulating, and Gram positive. However, an increasing number of studies have shown that it could also be an important pathogen for humans, even causing life-threatening infection under certain conditions. However, understanding its pathogenic mechanism and treatment options still need to be improved; more clinical data are needed to explore it further. The frequency of E. lenta bacteremia is increased in patients with hematologic or solid organ cancer, diabetes mellitus and also in those with appendicitis. Eggerthella lenta was first described by Arnold Eggerth in 1935 , which was originally named Eubacterium lentum. E. lenta is a normal bacterium that can colonize the human gut, female reproductive tract, oral cavity, and prostate gland. Due to the nature of strictly anaerobic and slow growth, E. lenta is difficult to culture and identify. Although, until recently, several microbial identification techniques, particularly mass spectrometry, were used to identify bacteria, an increasing number of E. lenta infections in humans have been reported, referring to bloodstream infection, liver abscess, bacterial vaginosis and meningitis. However, a unified standard treatment and its pathogenic mechanism have not yet been recognized. References: Jiang, S., E, J., Wang, D. et al. Eggerthella lenta bacteremia successfully treated with ceftizoxime: case report and review of the literature. Eur J Med Res 26, 111 (2021). https://doi.org/10.1186/s40001-021-00582-y
the only essential omega-6 fatty acid and must be obtained from the diet